While the manuscript was being prepared, a number of research revealed that METTL3 may control PD-L1 expression or be involved in immunotherapy for lung cancer and colorectal cancer [54–56], implying the complicated role of METTL3 in carcinogenesis. This evidence concerns the gene CD274 and lung carcinoma.